Compare AMPH & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | GDRX |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2005 | 2020 |
| Metric | AMPH | GDRX |
|---|---|---|
| Price | $26.04 | $3.61 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 14 |
| Target Price | ★ $22.50 | $3.95 |
| AVG Volume (30 Days) | 400.5K | ★ 878.1K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | ★ 0.81 | 0.03 |
| Revenue | $719,887,000.00 | ★ $796,853,000.00 |
| Revenue This Year | $3.87 | $0.20 |
| Revenue Next Year | $4.90 | $4.72 |
| P/E Ratio | ★ $32.44 | $119.33 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $16.65 | $1.77 |
| 52 Week High | $29.52 | $4.05 |
| Indicator | AMPH | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 60.70 |
| Support Level | $25.23 | $3.26 |
| Resistance Level | $27.45 | $3.89 |
| Average True Range (ATR) | 0.83 | 0.12 |
| MACD | -0.15 | 0.03 |
| Stochastic Oscillator | 49.28 | 91.46 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.